HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natasha Kormanik Selected Research

Lenalidomide (CC 5013)

11/2017FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Natasha Kormanik Research Topics

Disease

1Infections
11/2017
1Multiple Myeloma
11/2017
1Neoplasms (Cancer)
11/2017

Drug/Important Bio-Agent (IBA)

1elotuzumabIBA
11/2017
1Lenalidomide (CC 5013)FDA Link
11/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2017

Therapy/Procedure

1Therapeutics
11/2017